Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-081898
Filing Date
2021-06-16
Accepted
2021-06-16 13:01:35
Documents
2
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2119874d2_4.html 4  
1 OWNERSHIP DOCUMENT tm2119874d2_4.xml 4 3820
2 EXHIBIT 24 tm2119874d2_ex24.htm EX-24 8312
  Complete submission text file 0001104659-21-081898.txt   13626
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Issuer) CIK: 0001571934 (see all company filings)

EIN.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROTROPE, INE. 205 EAST 42ND STREET - 20TH FLOOR NEW YORK NY 10017
Business Address
Alkon Daniel L. (Reporting) CIK: 0001686138 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40458 | Film No.: 211020975